Examples of using Impaired liver function in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Impaired liver function.
Patients with impaired liver function.
Impaired liver function due to metastases.
Patients with an impaired liver function.
Impaired liver function due to cirrhosis.
In rare cases, impaired liver function.
Too prolonged steroid use can be a hepatotoxic encounter with impaired liver function.
Rare: impaired liver function.
Do not use in dogs with impaired liver function.
Consequently, impaired liver function is not expected to affect the pharmacokinetics of elosulfase alfa.
Do not use in dogs with impaired liver function.
Consequently, impaired liver function is not expected to affect the pharmacokinetics of laronidase in a clinically significant way.
Administration to animals with an impaired liver function.
In patients with impaired liver function, lactate clearance may be restricted.
However, steroid hormones may be poorly metabolized in women with impaired liver function.
Associated signs may be impaired liver function, chronic problems with the gastrointestinal tract.
This is considered not to be clinically relevant for patients with mildly impaired liver function.
In patients with mildly impaired liver function, a daily dose of 30 mg lansoprazole should not be exceeded.
Hepatic impairment The pharmacokinetic properties have not been investigated in patients with impaired liver function.
In patients with moderately impaired liver function, a daily dose of 15 mg lansoprazole should not be exceeded.
First of all, it is not recommended for those who have hypersensitivity to the components of the drug,as well as people with impaired liver function.
The pharmacokinetics of zonisamide in patients with impaired liver function have not been adequately studied.
Consequently, impaired liver function is not expected to affect the pharmacokinetics of galsulfase in a clinically significant way.
Due to limited experience,the safety and efficacy of Dynepo could not be assessed in patients with impaired liver function.
In patients with mildly impaired liver function(Child-Pugh class A) no relevant changes in the pharmacokinetics have been observed.
Active liver disease was an exclusion criteria in all studies of Nespo,therefore no data are available from patients with impaired liver function.
Impaired liver function due to cirrhosis has been shown to lead to increased plasma concentrations of gefitinib see section 5.2.
As metabolism is expected to occur by peptide hydrolysis, an impaired liver function is not expected to affect the pharmacokinetics.
Patients with severely impaired liver function should not take Lansoprazol AbZ, nor should they be given combination therapy with clarithromycin.
Due to limited experience, the efficacy andsafety of epoetin theta could not be assessed in patients with impaired liver function or homozygous sickle cell anaemia.